1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Anti-aging Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Anti-aging Market, by Products Type
8.1.1. Anti-wrinkle
8.1.1.1. Market Revenue and Forecast
8.1.2. Hair color
8.1.2.1. Market Revenue and Forecast
8.1.3. Ultraviolet absorption
8.1.3.1. Market Revenue and Forecast
8.1.4. Anti-stretch mark
8.1.4.1. Market Revenue and Forecast
9.1. Anti-aging Market, by Treatment Type
9.1.1. Hair restoration
9.1.1.1. Market Revenue and Forecast
9.1.2. Anti-pigmentation
9.1.2.1. Market Revenue and Forecast
9.1.3. Adult acne therapy
9.1.3.1. Market Revenue and Forecast
9.1.4. Breast augmentation
9.1.4.1. Market Revenue and Forecast
9.1.5. Liposuction
9.1.5.1. Market Revenue and Forecast
9.1.6. Chemical Peel
9.1.6.1. Market Revenue and Forecast
10.1. Anti-aging Market, by Demography Type
10.1.1. Generation X
10.1.1.1. Market Revenue and Forecast
10.1.2. Baby Boomers
10.1.2.1. Market Revenue and Forecast
10.1.3. Generation Y
10.1.3.1. Market Revenue and Forecast
10.1.4. Generation Z
10.1.4.1. Market Revenue and Forecast
11.1. Anti-aging Market, by Devices Type
11.1.1. Anti-cellulite treatment
11.1.1.1. Market Revenue and Forecast
11.1.2. Laser aesthetic devices
11.1.2.1. Market Revenue and Forecast
11.1.3. Microdermabrasion devices
11.1.3.1. Market Revenue and Forecast
11.1.4. Radio frequency devices
11.1.4.1. Market Revenue and Forecast
11.1.5. Others
11.1.5.1. Market Revenue and Forecast
12.1. Anti-aging Market, by End User
12.1.1. Hospitals
12.1.1.1. Market Revenue and Forecast
12.1.2. Clinics
12.1.2.1. Market Revenue and Forecast
12.1.3. Home healthcare
12.1.3.1. Market Revenue and Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Products
13.1.2. Market Revenue and Forecast, by Treatment
13.1.3. Market Revenue and Forecast, by Demography
13.1.4. Market Revenue and Forecast, by Devices
13.1.5. Market Revenue and Forecast, by End User
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Products
13.1.6.2. Market Revenue and Forecast, by Treatment
13.1.6.3. Market Revenue and Forecast, by Demography
13.1.6.4. Market Revenue and Forecast, by Devices
13.1.7. Market Revenue and Forecast, by End User
13.1.8. Rest of North America
13.1.8.1. Market Revenue and Forecast, by Products
13.1.8.2. Market Revenue and Forecast, by Treatment
13.1.8.3. Market Revenue and Forecast, by Demography
13.1.8.4. Market Revenue and Forecast, by Devices
13.1.8.5. Market Revenue and Forecast, by End User
13.2. Europe
13.2.1. Market Revenue and Forecast, by Products
13.2.2. Market Revenue and Forecast, by Treatment
13.2.3. Market Revenue and Forecast, by Demography
13.2.4. Market Revenue and Forecast, by Devices
13.2.5. Market Revenue and Forecast, by End User
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Products
13.2.6.2. Market Revenue and Forecast, by Treatment
13.2.6.3. Market Revenue and Forecast, by Demography
13.2.7. Market Revenue and Forecast, by Devices
13.2.8. Market Revenue and Forecast, by End User
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Products
13.2.9.2. Market Revenue and Forecast, by Treatment
13.2.9.3. Market Revenue and Forecast, by Demography
13.2.10. Market Revenue and Forecast, by Devices
13.2.11. Market Revenue and Forecast, by End User
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Products
13.2.12.2. Market Revenue and Forecast, by Treatment
13.2.12.3. Market Revenue and Forecast, by Demography
13.2.12.4. Market Revenue and Forecast, by Devices
13.2.13. Market Revenue and Forecast, by End User
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Products
13.2.14.2. Market Revenue and Forecast, by Treatment
13.2.14.3. Market Revenue and Forecast, by Demography
13.2.14.4. Market Revenue and Forecast, by Devices
13.2.15. Market Revenue and Forecast, by End User
13.3. APAC
13.3.1. Market Revenue and Forecast, by Products
13.3.2. Market Revenue and Forecast, by Treatment
13.3.3. Market Revenue and Forecast, by Demography
13.3.4. Market Revenue and Forecast, by Devices
13.3.5. Market Revenue and Forecast, by End User
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Products
13.3.6.2. Market Revenue and Forecast, by Treatment
13.3.6.3. Market Revenue and Forecast, by Demography
13.3.6.4. Market Revenue and Forecast, by Devices
13.3.7. Market Revenue and Forecast, by End User
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Products
13.3.8.2. Market Revenue and Forecast, by Treatment
13.3.8.3. Market Revenue and Forecast, by Demography
13.3.8.4. Market Revenue and Forecast, by Devices
13.3.9. Market Revenue and Forecast, by End User
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Products
13.3.10.2. Market Revenue and Forecast, by Treatment
13.3.10.3. Market Revenue and Forecast, by Demography
13.3.10.4. Market Revenue and Forecast, by Devices
13.3.10.5. Market Revenue and Forecast, by End User
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Products
13.3.11.2. Market Revenue and Forecast, by Treatment
13.3.11.3. Market Revenue and Forecast, by Demography
13.3.11.4. Market Revenue and Forecast, by Devices
13.3.11.5. Market Revenue and Forecast, by End User
13.4. MEA
13.4.1. Market Revenue and Forecast, by Products
13.4.2. Market Revenue and Forecast, by Treatment
13.4.3. Market Revenue and Forecast, by Demography
13.4.4. Market Revenue and Forecast, by Devices
13.4.5. Market Revenue and Forecast, by End User
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Products
13.4.6.2. Market Revenue and Forecast, by Treatment
13.4.6.3. Market Revenue and Forecast, by Demography
13.4.6.4. Market Revenue and Forecast, by Devices
13.4.7. Market Revenue and Forecast, by End User
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Products
13.4.8.2. Market Revenue and Forecast, by Treatment
13.4.8.3. Market Revenue and Forecast, by Demography
13.4.8.4. Market Revenue and Forecast, by Devices
13.4.9. Market Revenue and Forecast, by End User
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Products
13.4.10.2. Market Revenue and Forecast, by Treatment
13.4.10.3. Market Revenue and Forecast, by Demography
13.4.10.4. Market Revenue and Forecast, by Devices
13.4.10.5. Market Revenue and Forecast, by End User
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Products
13.4.11.2. Market Revenue and Forecast, by Treatment
13.4.11.3. Market Revenue and Forecast, by Demography
13.4.11.4. Market Revenue and Forecast, by Devices
13.4.11.5. Market Revenue and Forecast, by End User
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Products
13.5.2. Market Revenue and Forecast, by Treatment
13.5.3. Market Revenue and Forecast, by Demography
13.5.4. Market Revenue and Forecast, by Devices
13.5.5. Market Revenue and Forecast, by End User
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Products
13.5.6.2. Market Revenue and Forecast, by Treatment
13.5.6.3. Market Revenue and Forecast, by Demography
13.5.6.4. Market Revenue and Forecast, by Devices
13.5.7. Market Revenue and Forecast, by End User
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Products
13.5.8.2. Market Revenue and Forecast, by Treatment
13.5.8.3. Market Revenue and Forecast, by Demography
13.5.8.4. Market Revenue and Forecast, by Devices
13.5.8.5. Market Revenue and Forecast, by End User
14.1. Unilever Group
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. GALDERMA LABORATORIES L.P.
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Procter & Gamble (P&G) Company
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Nu Skin Enterprises Inc.
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Hologic Inc.
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Pierre Fabre S.A.
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Shiseido Company Limited
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Candela Corporation
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Home Skinovations Ltd.
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Estee Lauder
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
16.1. About Us
16.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
